---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-102775"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:46:50.795443+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Mark S. Blumenkranz resigns from KALA BIO board immediately

## Summary
- Mark S. Blumenkranz, M.D. resigned from the Board of Directors effective September 23, 2024.
- He also stepped down from the Audit Committee and Nominating and Corporate Governance Committee.
- Resignation was not related to any disagreement with the company's operations, policies, or practices.
- No replacement director has been announced as of the filing date.

## SEC filing metadata
- accession: 0001104659-24-102775
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000110465924102775/0001104659-24-102775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000110465924102775/tm2424692d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-102775
- JSON: https://secwatch.observer/filing/0001104659-24-102775.json
- Plain text: https://secwatch.observer/filing/0001104659-24-102775.txt

## Key facts
- Executive change
  Mark S. Blumenkranz resigned as Director at KALA BIO, Inc..
  - Action: resigned
  - Role: Director
  source text: On September 23, 2024, Mark S. Blumenkranz, M.D. notified KALA BIO, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000110465924102775/0001104659-24-102775-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.